SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
Go back to SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types| (NASDAQ: SKIN) | Delayed: 0.73 -0.01 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.74 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.72 | EPS | $ | |||
| Volume | 687,787 | |||||
| (NASDAQ: SKIN) | Delayed: 0.73 -0.01 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.74 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.72 | EPS | $ | |||
| Volume | 687,787 | |||||

